NASDAQ: AUPHAurinia Pharmaceuticals Inc Stock Ownership - Who owns Aurinia Pharmaceuticals?
Insider buying vs selling
Have Aurinia Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Kevin Tang | Chief Executive Officer | 2026-06-02 | 206,005 | $15.28 | $3.15MBuy |
| Kevin Tang | Chief Executive Officer | 2026-06-01 | 343,521 | $15.28 | $5.25MBuy |
| Kevin Tang | Chief Executive Officer | 2026-06-01 | 99 | $15.34 | $1.52kBuy |
| Kevin Tang | Chief Executive Officer | 2026-05-29 | 2,299 | $15.35 | $35.29kBuy |
| Kevin Tang | Chief Executive Officer | 2026-05-29 | 262,682 | $15.31 | $4.02MBuy |
| Greg Keenan | SVP Chief Medical Officer | 2026-03-06 | 8,069 | $14.32 | $115.55kSell |
| Kevin Tang | Director | 2026-03-03 | 184,208 | $14.22 | $2.62MBuy |
| Kevin Tang | Director | 2026-03-02 | 83,561 | $14.33 | $1.20MBuy |
| Peter Greenleaf | Chief Executive Officer | 2026-03-02 | 100,890 | $14.21 | $1.43MSell |
| Joseph M. Miller | Chief Financial Officer | 2026-03-02 | 37,511 | $14.21 | $533.03kSell |
AUPH insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AUPH insiders and whales buy or sell their stock.
AUPH Shareholders
What type of owners hold Aurinia Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Kevin Tang | 10.14% | 13,044,106 | $211.58M | Insider |
| Tang Capital Management LLC | 9.51% | 12,229,500 | $198.36M | Institution |
| Blackrock Inc | 6.10% | 7,845,521 | $127.25M | Institution |
| Nea Management Company LLC | 3.09% | 3,969,834 | $64.39M | Institution |
| Two Sigma Investments LP | 2.67% | 3,428,705 | $55.61M | Institution |
| Arrowstreet Capital Limited Partnership | 2.55% | 3,284,368 | $53.27M | Institution |
| State Street Corp | 1.97% | 2,527,099 | $40.99M | Institution |
| Morgan Stanley | 1.74% | 2,232,548 | $36.21M | Institution |
| Marshall Wace LLP | 1.46% | 1,874,597 | $30.41M | Institution |
| Peter Greenleaf | 1.43% | 1,840,379 | $29.85M | Insider |
AUPH vs Biotech Stocks
Aurinia Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.